Regulation of MAP kinases by the VHR dual-specific phosphatase: implications for cell growth and differentiation

Fabio Cerignoli1, Souad Rahmouni, Ze'ev Ronai

  • 1The Burnham Institute for Medical Research, La Jolla, California 92037, USA.

Insights

The Vaccinia H1-related (VHR) phosphatase regulates cell cycle progression by controlling Erk and Jnk kinase activity. Loss of VHR leads to cell cycle arrest and senescence, highlighting VHR's crucial role in cell fate.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Transient activation of Erk and Jnk kinases promotes cell growth.
  • Prolonged activation of Erk and Jnk can induce cell cycle arrest, differentiation, and senescence.
  • The role of specific phosphatases in regulating these kinase activities during the cell cycle is not fully understood.

Purpose of the Study:

  • To investigate the role of the Vaccinia H1-related (VHR) dual-specific phosphatase in cell cycle regulation.
  • To determine how VHR expression and activity affect Erk and Jnk kinase signaling throughout the cell cycle.
  • To elucidate the contribution of VHR to cell cycle arrest, differentiation, and senescence phenotypes.

Main Methods:

  • Analysis of VHR expression during cell cycle progression.
  • Generation and characterization of VHR-deficient cells.
  • Assessment of Erk and Jnk kinase activity in VHR-deficient cells.
  • Gene expression profiling in VHR-deficient cells.
  • Inhibition of Jnk and Erk signaling pathways in VHR-deficient cells.

Main Results:

  • VHR expression fluctuates during cell cycle progression, impacting Erk and Jnk activity in a cell cycle-dependent manner.
  • VHR-deficient cells exhibited cell cycle arrest at the G(1)/S and G(2)/M transitions and displayed senescence phenotypes.
  • Loss of VHR led to upregulation of p21(Cip/Waf1) and downregulation of genes involved in cell cycle regulation, DNA replication, transcription, and mRNA processing.
  • Serum-induced Jnk and Erk activation was elevated in VHR-deficient cells and was essential for G(1)/S and G(2)/M arrest, with inhibition of these kinases attenuating the blocks.

Conclusions:

  • VHR acts as a critical regulator of Jnk and Erk activity during cell cycle progression.
  • VHR's function is essential for preventing aberrant cell cycle arrest, differentiation, and senescence.
  • VHR provides a key regulatory layer in mitogen-activated protein kinase signaling pathways controlling cell fate.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...